Pharmaceuticals News and Research

RSS

Study: Brain cell death may trigger multiple sclerosis

Multiple sclerosis (MS) may be triggered by the death of brain cells that make myelin, the insulation around nerve fibers, according to research on a novel mouse model developed by scientists from the University of Chicago and Northwestern Medicine. The death of these cells initiates an autoimmune response against myelin, the main characteristic of the disease, which leads to MS-like symptoms in mice.

14 Dec 2015

VistaPharm announces launch of Potassium Chloride Solution

VistaPharm today announced that it has launched Potassium Chloride Solution, USP, 10% in Unit Dose. The product is supplied to the market in a 50 count case of 30mL unit dose cups.

14 Dec 2015

Validus, Wood Creek announce acquisition of U.S. rights to several Sanofi US products

Validus Pharmaceuticals LLC, together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the U.S. rights to several well-known product lines from Sanofi US: Anzemet (dolasetron mesylate) Injection and Tablets, Claforan (cefotaxime) Injection/IM/IV, Demerol (meperidine hydrochloride) Tablets, Drisdol (ergocalciferol) Capsules and Oral Solution, Hiprex (methenamine hippurate) Tablets, Lasix (furosemide) Tablets, Norpramin (desipramine hydrochloride) Tablets and Trental (pentoxifylline) Tablets.

14 Dec 2015

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced a collaboration agreement with Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company.

14 Dec 2015

Complix signs agreement with Selexis to advance production of autoimmune drug candidate CMX-02

Complix NV, a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, for the treatment of cancer and severe autoimmune diseases, announces that it is advancing the development of CMX-02, a potential treatment of severe autoimmune disease.

14 Dec 2015

CTI BioPharma earns $10 million milestone payment from Teva for TRISENOX (arsenic trioxide)

CTI BioPharma Corp. today announced that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd. (Teva) related to the achievement of sales milestones for TRISENOX (arsenic trioxide).

14 Dec 2015

Best Practices undertakes study to develop benchmarks for library services within biopharmaceutical industry

Biopharmaceutical and Medical Device executives are constantly looking to their corporate libraries to provide them with vital information in regards to research, development and maintenance of e-resources. Despite this, rapid advances in technology, mixed with plummeting resources have made it increasingly difficult for libraries to effectively balance their budget, resource and service levels within organizations.

14 Dec 2015

WuXi PharmaTech announces winners of Life Science and Chemistry Awards

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, announced the winners of the ninth annual WuXi PharmaTech Life Science and Chemistry Awards at a ceremony held on December 13 at Diaoyutai State Guesthouse in Beijing.

14 Dec 2015

Study offers insight into how female Viagra affects the brain

As the drug touted as "the female Viagra" comes to market, researchers at the University of Wisconsin-Madison are learning more about how the drug, called flibanserin, affects the brain.

13 Dec 2015

Innovative Social Media Listening programs launched to boost performance of pharmaceutical industry

Online disease state discussions among patients, physicians, caregivers and other key customer groups is flourishing across both established and emerging online channels. Recognizing the potential value of these online discussions, savvy healthcare companies have launched innovative Social Media Listening programs to capture critical market insights.

13 Dec 2015

Rutgers scientists uncover biological pathways that provide insight into tiny cell bubbles

Rutgers scientists have uncovered biological pathways in the roundworm that provide insight into how tiny bubbles released by cells can have beneficial health effects, like promoting tissue repair, or may play a diabolical role and carry disease signals for cancer or neurodegenerative diseases like Alzheimer's.

12 Dec 2015

ASU-led researchers add new worldwide resource to explore genes' deep and hidden messages

After a decade-long $3 billion international effort, scientists heralded the 2001 completion of the human genome as a moon landing achievement for biology and the key to finally solving intractable diseases like cancer.

12 Dec 2015

Swiss students not in favor of pharmacological cognitive enhancement

Switzerland has honest students: The vast majority of the students that were questioned were against pharmacological cognitive enhancement. Yet the topic should be addressed more actively by the universities, asks the study that was published in the journal Plos One.

12 Dec 2015

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

11 Dec 2015

Biogen begins ISIS-SOD1 Rx Phase 1/2 clinical study in patients with amyotrophic lateral sclerosis

Isis Pharmaceuticals, Inc. today announced that its partner, Biogen, has initiated a Phase 1/2 clinical study of ISIS-SOD1 Rx (BIIB067) in patients with amyotrophic lateral sclerosis (ALS).

11 Dec 2015

FDA grants Fast Track status to Cardiorentis' Ularitide for treatment of ADHF

Cardiorentis AG, a privately held biopharmaceutical company, today announced that the U.S. Food and Drug Administration has granted Fast Track status to Ularitide, an investigational therapy for the treatment of acute decompensated heart failure (ADHF).

11 Dec 2015

UC San Diego biologists develop a method to screen natural products for new antibiotics

Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.

11 Dec 2015

UC San Diego Health offers safe weight loss option for patients

Patients seeking rapid but safe weight loss have a new option at the Bariatric Metabolic Institute at UC San Diego Health. During an outpatient procedure, surgeons place an adjustable saline balloon in the stomach. The volume and shape of the balloon take up space in the stomach, which encourages food portion control. The device, called Orbera, has been shown to reduce total body weight by 10 percent.

11 Dec 2015

TSRI-led study shows how different drugs regulate protein linked to asthma, obesity and diabetes

A new study, led by scientists at The Scripps Research Institute, shows how different pharmaceutical drugs hit either the "on" or "off" switch of a signaling protein linked to asthma, obesity and type 2 diabetes.

11 Dec 2015

New Swabbable Needleless Injection Sites with Barbs from Qosina

Qosina is pleased to announce the addition of three new barbed swabbable needleless injection sites (#80209-#80211), in stock and ready for immediate delivery.

10 Dec 2015

Pharmaceuticals News and Research

Study: Brain cell death may trigger multiple sclerosis

VistaPharm announces launch of Potassium Chloride Solution

Validus, Wood Creek announce acquisition of U.S. rights to several Sanofi US products

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Complix signs agreement with Selexis to advance production of autoimmune drug candidate CMX-02

CTI BioPharma earns $10 million milestone payment from Teva for TRISENOX (arsenic trioxide)

Best Practices undertakes study to develop benchmarks for library services within biopharmaceutical industry

WuXi PharmaTech announces winners of Life Science and Chemistry Awards

Study offers insight into how female Viagra affects the brain

Innovative Social Media Listening programs launched to boost performance of pharmaceutical industry

Rutgers scientists uncover biological pathways that provide insight into tiny cell bubbles

ASU-led researchers add new worldwide resource to explore genes' deep and hidden messages

Swiss students not in favor of pharmacological cognitive enhancement

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Biogen begins ISIS-SOD1 Rx Phase 1/2 clinical study in patients with amyotrophic lateral sclerosis

FDA grants Fast Track status to Cardiorentis' Ularitide for treatment of ADHF

UC San Diego biologists develop a method to screen natural products for new antibiotics

UC San Diego Health offers safe weight loss option for patients

TSRI-led study shows how different drugs regulate protein linked to asthma, obesity and diabetes

New Swabbable Needleless Injection Sites with Barbs from Qosina

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring